Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by biggerron Feb 14, 2019 9:24am

100 Views

Post# 29363134

RE:RE:10 YEARS later and back up to .41 cents

when they announce the start of Phase 2 it will be time to buy because it's gonna be very short compared to Phase 1 in which they had to determine safety procedures and dosage. In Phase 2 the dosage and safety are already established, all they have to do is the 2-hour procedure and the cured patients will start rolling out one after the other, god willing

Bullboard Posts

Full Circle Lithium goes global with its battery fire-fighter